Cargando…
Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
BACKGROUND: To investigate the association between serum 25-hydroxyvitamin D levels and its effect on adverse clinical outcomes, and parameters of immune function and mortality due to a SARS-CoV-2 infection. STUDY DESIGN: The hospital data of 235 patients infected with COVID-19 were analyzed. RESULT...
Autores principales: | Maghbooli, Zhila, Sahraian, Mohammad Ali, Ebrahimi, Mehdi, Pazoki, Marzieh, Kafan, Samira, Tabriz, Hedieh Moradi, Hadadi, Azar, Montazeri, Mahnaz, Nasiri, Mehrad, Shirvani, Arash, Holick, Michael F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7518605/ https://www.ncbi.nlm.nih.gov/pubmed/32976513 http://dx.doi.org/10.1371/journal.pone.0239799 |
Ejemplares similares
-
Treatment With 25-Hydroxyvitamin D(3) (Calcifediol) Is Associated With a Reduction in the Blood Neutrophil-to-Lymphocyte Ratio Marker of Disease Severity in Hospitalized Patients With COVID-19: A Pilot Multicenter, Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
por: Maghbooli, Zhila, et al.
Publicado: (2021) -
Expression of Concern: Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection
Publicado: (2020) -
Prognostic significance of CHADS(2) and CHA(2)DS(2)-VASc scores to predict unfavorable outcomes in hospitalized patients with COVID-19
por: Montazeri, Mahnaz, et al.
Publicado: (2022) -
Alterations in circulating levels of vitamin D binding protein, total and bioavailability of vitamin D in diabetic retinopathy patients
por: Maghbooli, Zhila, et al.
Publicado: (2022) -
Reduction in circulating vitamin D binding protein in patients with multiple sclerosis
por: Maghbooli, Zhila, et al.
Publicado: (2021)